[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1193 Engrossed Amendment Senate (EAS)]

<DOC>
  
  
  
  
  
  
  
  
  
  

                  In the Senate of the United States,

                                                      December 1, 2022.
    Resolved, That the bill from the House of Representatives (H.R. 
1193) entitled ``An Act to amend title IV of the Public Health Service 
Act to direct the Director of the National Institutes of Health, in 
consultation with the Director of the National Heart, Lung, and Blood 
Institute, to establish a program under which the Director of the 
National Institutes of Health shall support or conduct research on 
valvular heart disease, and for other purposes.'', do pass with the 
following

                               AMENDMENT:

             Strike all after the enacting clause and insert the 
      following:

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Cardiovascular Advances in Research 
and Opportunities Legacy Act''.

SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the ``Secretary'') shall, as 
appropriate, continue activities related to research, education, and 
awareness of valvular heart diseases.
    (b) NIH Research Related to Valvular Heart Diseases.--
            (1) In general.--The Director of the National Institutes of 
        Health, in consultation with the Director of the National 
        Heart, Lung, and Blood Institute, may support or conduct 
        research regarding valvular heart diseases.
            (2) Support further research.--In order to improve 
        information on, and understanding of, causation and risk 
        factors for valvular heart diseases, research conducted or 
        supported under this subsection for such diseases may include 
        the following:
                    (A) Use of advanced technological imaging and other 
                relevant methods to generate data related to valvular 
                heart diseases.
                    (B) Assessing potential risk factors for sudden 
                cardiac arrest or sudden cardiac death from valvular 
                heart diseases.
                    (C) Other activities, as appropriate, in order to 
                improve the availability of information on, and advance 
                research related to, valvular heart diseases.
            (3) Mitral valve prolapse workshop.--Not later than 2 years 
        after the date of enactment of this Act, the Director of the 
        National Heart, Lung, and Blood Institute shall, as 
        appropriate, convene a workshop composed of subject matter 
        experts and stakeholders to identify research needs and 
        opportunities to develop recommendations for the identification 
        and treatment of individuals with mitral valve prolapse, 
        including such individuals who may be at risk for sudden 
        cardiac arrest or sudden cardiac death.
    (c) Prevention Activities to Improve Awareness of Sudden Cardiac 
Death as a Result of Valvular Heart Diseases.--
            (1) In general.--The Secretary may carry out activities to 
        increase education and awareness of valvular heart diseases in 
        order to reduce the incidence of sudden cardiac death caused by 
        such diseases. The Secretary may--
                    (A) award grants or contracts to public or 
                nonprofit private entities to carry out activities 
                under this subsection; and
                    (B) directly, or through grants or contracts, 
                provide technical assistance with respect to such 
                activities.
            (2) Certain activities.--Upon availability of applicable 
        data, projects carried out under paragraph (1) may include--
                    (A) continuing activities at the Centers for 
                Disease Control and Prevention related to valvular 
                heart diseases;
                    (B) improving the awareness of the public 
                concerning any risk factors for, the symptoms of, and 
                the public health impact of, valvular heart diseases; 
                and
                    (C) enhancing public health data collection and 
                improving the quality of such data, as appropriate, 
                regarding cardiac arrests, including cardiac arrests 
                that occur outside of the hospital.
            (3) Grant prioritization.--The Secretary may, in awarding 
        grants or entering into contracts pursuant to paragraph (1), 
        give priority to entities seeking to carry out projects for 
        populations most impacted by valvular heart diseases.
            (4) Coordination of activities.--The Secretary shall, as 
        appropriate, ensure that activities under this section are 
        coordinated with other agencies and offices of the Department 
        of Health and Human Services that carry out activities 
        regarding valvular heart diseases.
            (5) Best practices.--The Secretary shall, as applicable and 
        appropriate, identify and disseminate best practices for 
        relevant health care providers related to valvular heart 
        diseases.
    (d) Authorization of Appropriations.--For purposes of carrying out 
this section, there are authorized to be appropriated $28,000,000 for 
each of fiscal years 2023 through 2027.

            Attest:

                                                             Secretary.
117th CONGRESS

  2d Session

                               H.R. 1193

_______________________________________________________________________

                               AMENDMENT